AirNexis Therapeutics, Inc.
Biotechnology · Palo Alto · United States
0 followers
AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)
https://airnexis.com ↗
Reviews from employees
No reviews yet.
Open jobs at AirNexis Therapeutics, Inc.
No open jobs at the moment.